Parameters for the rational design of genetic toxoid vaccines.
Burnette
W N
WN
Molecular Pharmaceutics Corporation, Westlake Village, California 91362, USA.
D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control; D001427:Bacterial Toxins / Q000737:chemistry / Q000276:immunology*; D001428:Bacterial Vaccines; D002771:Cholera / Q000276:immunology* / Q000517:prevention & control; D002772:Cholera Toxin / Q000276:immunology; D015195:Drug Design; D006801:Humans; D008961:Models, Structural; D011065:Poly(ADP-ribose) Polymerases / Q000737:chemistry / Q000276:immunology; D011487:Protein Conformation; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic
D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D002772:Cholera Toxin; D011065:Poly(ADP-ribose) Polymerases